BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24913711)

  • 1. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
    Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterisation of acral melanoma cell lines.
    Furney SJ; Turajlic S; Fenwick K; Lambros MB; MacKay A; Ricken G; Mitsopoulos C; Kozarewa I; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Reis-Filho JS; Herlyn M; Murata H; Marais R
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):488-92. PubMed ID: 22578220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
    Hendricks WPD; Zismann V; Sivaprakasam K; Legendre C; Poorman K; Tembe W; Perdigones N; Kiefer J; Liang W; DeLuca V; Stark M; Ruhe A; Froman R; Duesbery NS; Washington M; Aldrich J; Neff MW; Huentelman MJ; Hayward N; Brown K; Thamm D; Post G; Khanna C; Davis B; Breen M; Sekulic A; Trent JM
    PLoS Genet; 2018 Sep; 14(9):e1007589. PubMed ID: 30188888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome sequencing of matched primary and metastatic acral melanomas.
    Turajlic S; Furney SJ; Lambros MB; Mitsopoulos C; Kozarewa I; Geyer FC; Mackay A; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Thomas M; Stamp G; Larkin J; Reis-Filho JS; Marais R
    Genome Res; 2012 Feb; 22(2):196-207. PubMed ID: 22183965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
    Moon KR; Choi YD; Kim JM; Jin S; Shin MH; Shim HJ; Lee JB; Yun SJ
    J Invest Dermatol; 2018 Apr; 138(4):933-945. PubMed ID: 29191620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.
    Rawson RV; Johansson PA; Hayward NK; Waddell N; Patch AM; Lo S; Pearson JV; Thompson JF; Mann GJ; Scolyer RA; Wilmott JS
    Lab Invest; 2017 Feb; 97(2):130-145. PubMed ID: 28067894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.
    Zou Z; Ou Q; Ren Y; Lv Q; Qin L; Zhao L; Su S; Wu X; Bao H; Wang A; Zhu D; Wang X; Shao YW; Liu B
    Pigment Cell Melanoma Res; 2020 Jul; 33(4):601-611. PubMed ID: 31944535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.
    Newell F; Wilmott JS; Johansson PA; Nones K; Addala V; Mukhopadhyay P; Broit N; Amato CM; Van Gulick R; Kazakoff SH; Patch AM; Koufariotis LT; Lakis V; Leonard C; Wood S; Holmes O; Xu Q; Lewis K; Medina T; Gonzalez R; Saw RPM; Spillane AJ; Stretch JR; Rawson RV; Ferguson PM; Dodds TJ; Thompson JF; Long GV; Levesque MP; Robinson WA; Pearson JV; Mann GJ; Scolyer RA; Waddell N; Hayward NK
    Nat Commun; 2020 Oct; 11(1):5259. PubMed ID: 33067454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma.
    Furney SJ; Turajlic S; Stamp G; Nohadani M; Carlisle A; Thomas JM; Hayes A; Strauss D; Gore M; van den Oord J; Larkin J; Marais R
    J Pathol; 2013 Jul; 230(3):261-9. PubMed ID: 23620124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
    Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
    Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.
    Klemen ND; Wang M; Rubinstein JC; Olino K; Clune J; Ariyan S; Cha C; Weiss SA; Kluger HM; Sznol M
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32209601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations identified by whole-exome sequencing in acral melanoma.
    Lim Y; Yoon D; Lee DY
    J Am Acad Dermatol; 2020 Dec; 83(6):1792-1794. PubMed ID: 32278801
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.
    Vergara IA; Mintoff CP; Sandhu S; McIntosh L; Young RJ; Wong SQ; Colebatch A; Cameron DL; Kwon JL; Wolfe R; Peng A; Ellul J; Dou X; Fedele C; Boyle S; Arnau GM; Raleigh J; Hatzimihalis A; Szeto P; Mooi J; Widmer DS; Cheng PF; Amann V; Dummer R; Hayward N; Wilmott J; Scolyer RA; Cho RJ; Bowtell D; Thorne H; Alsop K; Cordner S; Woodford N; Leditschke J; O'Brien P; Dawson SJ; McArthur GA; Mann GJ; Levesque MP; Papenfuss AT; Shackleton M
    Nat Commun; 2021 Mar; 12(1):1434. PubMed ID: 33664264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
    Gui J; Guo Z; Wu D
    J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
    Yun J; Lee J; Jang J; Lee EJ; Jang KT; Kim JH; Kim KM
    APMIS; 2011 Jun; 119(6):330-5. PubMed ID: 21569090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
    Wang M; Banik I; Shain AH; Yeh I; Bastian BC
    Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational profiling of acral melanomas in Korean populations.
    Shim JH; Shin HT; Park J; Park JH; Lee JH; Yang JM; Kim DH; Jang KT; Lee DY
    Exp Dermatol; 2017 Oct; 26(10):883-888. PubMed ID: 28191690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.
    Torres-Cabala CA; Wang WL; Trent J; Yang D; Chen S; Galbincea J; Kim KB; Woodman S; Davies M; Plaza JA; Nash JW; Prieto VG; Lazar AJ; Ivan D
    Mod Pathol; 2009 Nov; 22(11):1446-56. PubMed ID: 19718013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.